Open AccessCLINICAL COURSE OF PERIODONTAL DISEASES IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS TREATED WITH BISPHOSPHONATES
Author(s) -
Marietta Sukhorukikh,
М. Н. Козлова,
Ekaterina Gorbatova,
L S Dzikovitskaya,
A.A. Bashtovoy
Publication year - 2021
Publication title -
archiv euromedica
Language(s) - English
Resource type - Journals
eISSN - 2199-885X
pISSN - 2193-3863
DOI - 10.35630/2199-885x/2021/11/2/29
Subject(s) - medicine , osteoporosis , dentistry , saliva , postmenopausal osteoporosis , periodontal disease , oral cavity , oral medicine , postmenopausal women , oral administration , bone mineral
The aim of the study was to assess the state of the clinical course of periodontal diseases in patients with postmenopausal osteoporosis (OP), depending on the long-term oral administration of various groups of bisphosphonates (BP). The study included 120 women aged 55–65 years with postmenopausal OP for at least three years who took complex antiosteoporetic therapy, including BP in tablet form. The dental examination included an examination of the oral cavity, the study of the pH of the oral fluid, the hygienic state of the mouth (the "Florida Probe" system). According to the results of the study, it was revealed that prolonged treatment of BP in tablets can provoke the development of inflammatory reactions in periodontal tissues. This phenomenon is associated with a shift in the pH of saliva to the acidic side, at which its buffer properties change.